Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis
R Naveen, Ioannis Parodis, Mrudula Joshi, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 7, pp. 2366-2376
Open Access | Times Cited: 19

Showing 19 citing articles:

Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 432-432
Open Access | Times Cited: 49
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review
Anna Stainer, Antonio Tonutti, Maria De Santis, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry
Andreina Manfredi, Marco Fornaro, Chiara Bazzani, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 4
Rheumatoid Arthritis and COVID-19 at the Intersection of Immunology and Infectious Diseases: A Related PRISMA Systematic Literature Review
Andreea-Iulia Vlădulescu-Trandafir, Violeta‐Claudia Bojincă, Constantin Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11149-11149
Open Access | Times Cited: 3
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study
R Naveen, Elena Nikiphorou, Mrudula Joshi, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 7, pp. 2453-2463
Open Access | Times Cited: 15
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 687-687
Open Access | Times Cited: 8
What rheumatologists need to know about mRNA vaccines: current status and future of mRNA vaccines in autoimmune inflammatory rheumatic diseases
Jin Kyun Park, Eun Bong Lee, Kevin Winthrop
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 687-695
Closed Access | Times Cited: 2
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey
R Naveen, Darpan R. Thakare, Masataka Kuwana, et al.
Rheumatology International (2023) Vol. 43, Iss. 7, pp. 1265-1275
Open Access | Times Cited: 7
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey
Mrinalini Dey, Bohdana Doskaliuk, Ioannis Parodis, et al.
Rheumatology International (2024)
Open Access | Times Cited: 1
COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus
Mrinalini Dey, Bohdana Doskaliuk, Julius Lindblom, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7542-7542
Open Access | Times Cited: 4
How Safe are COVID-19 Vaccines in Immune-Mediated Inflammatory Diseases? The SUCCEED Study
Olga Tsyruk, Gilaad G. Kaplan, Paul R. Fortin, et al.
(2024)
Open Access | Times Cited: 1
Knowledge mapping of COVID-19 and autoimmune diseases: a visual and bibliometric analysis
Youao Zhang, Zixuan Jia, Xia Xu, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3549-3564
Open Access | Times Cited: 3
Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination
Ji-Won Kim, Ju‐Yang Jung, Chang‐Hee Suh, et al.
Journal of Korean Medical Science (2023) Vol. 38, Iss. 32
Open Access | Times Cited: 3
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey
Sakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International (2023) Vol. 44, Iss. 1, pp. 89-97
Closed Access | Times Cited: 2
The impact of corona virus disease-2019 (COVID-19) vaccination on patients with systemic rheumatic diseases attending a tertiary care university-based hospital
Rasha E. Gheith, Eman Hany Elsebaie, A. Kandeel, et al.
The Egyptian Rheumatologist (2024) Vol. 46, Iss. 2, pp. 73-77
Closed Access
Efficacy and safety of inactivated SARS‐CoV‐2 vaccination in COVID‐19‐associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real‐world retrospective observational study
S. Liu, Ziyi Jin, Xuebing Feng, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 5
Closed Access
Digital Health and Self-Management in Idiopathic Inflammatory Myopathies: A Missed Opportunity?
Simone Battista, Benedetto Giardulli, C. Sieiro Santos, et al.
Current Rheumatology Reports (2024) Vol. 26, Iss. 11, pp. 383-391
Open Access
How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED Study
Olga Tsyruk, Gilaad G. Kaplan, Paul R. Fortin, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1027-1027
Open Access
Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting
María Torres-Rufas, Esther F. Vicente‐Rabaneda, Laura Cardeñoso, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 672-672
Open Access
Page 1

Scroll to top